A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab (AMG 827) in Subjects with Moderate to Severe Asthma

Published 2013 View Full Article

Authors

Keywords

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Volume 131, Issue 2, Pages AB230

Publisher

Elsevier BV

Online

2013-01-26

DOI

10.1016/j.jaci.2012.12.1486

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.